Single-cell resolution imaging of membrane-anchored hepatitis C virus NS3/4A protease activity

Biological Chemistry

Volumn 387, Issue 8, 2006, Pages 1075-1080

  Martin, Morgan M ^a   Jean, François ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Activity based probe; Cell based assay; Discosoma red fluorescent protein; Intracellular proteolysis; Juxtamembrane protease; Membrane bound serine protease; Viral protease

Indexed keywords

MEMBRANE ENZYME; NONSTRUCTURAL PROTEIN 3; PROTEIN NS3 4A; UNCLASSIFIED DRUG; VIRUS ENZYME; VIRUS RNA;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ARTICLE; ENDOPLASMIC RETICULUM; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME SPECIFICITY; FLUORESCENCE ANALYSIS; HEPATITIS C VIRUS; IMMUNOFLUORESCENCE; IN VIVO STUDY; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; SINGLE CELL RESOLUTION IMAGING; VIRUS DETECTION; VIRUS DIAGNOSIS; WESTERN BLOTTING;

BLOTTING, WESTERN; CARRIER PROTEINS; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; HEPACIVIRUS; HUMANS; INTRACELLULAR MEMBRANES; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, FLUORESCENCE; VIRAL NONSTRUCTURAL PROTEINS; VIRAL PROTEINS;

HEPATITIS C VIRUS;

EID: 33746879628     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2006.132     Document Type: Article

References (29)

1. Aizaki, H., Lee, K.J., Sung, V.M., Ishiko H., and Lai, M.M. (2004). Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts. Virology 324, 450-461.
2. Baruch, A., Jeffery, D.A., and Bogyo, M. (2004). Enzyme activity - it's all about image. Trends Cell Biol. 14, 29-35.
3. Bauvois, B. (2004). Transmembrane proteases in cell growth and invasion: new contributors to angiogenesis? Oncogene 23, 317-329.
4. Egger, D., Wolk, B., Gosert, R., Bianchi, L., Blum, H.E., Moradpour, D., and Bienz, K. (2002). Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. J. Virol. 76, 5974-5984.
5. Ehrmann, M. and Clausen, T. (2004). Proteolysis as a regulatory mechanism. Annu. Rev. Genet. 38, 709-724.
6. Elazar, M., Cheong, K.H., Liu, P., Greenberg, H.B., Rice, C.M., and Glenn, J.S. (2003). Amphipathic helix-dependent localization of NS5A mediates hepatitis C virus RNA replication. J. Virol. 77, 6055-6061.
7. Ferreon, J.C., Ferreon, A.C., Li, K., and Lemon, S.M. (2005). Molecular determinants of TRIP proteolysis mediated by the hepatitis C virus NS3/4A protease. J. Biol. Chem. 280, 20483-20492.
8. Golde, T.E. and Eckman, C.B. (2003). Physiologic and pathologic events mediated by intramembranous and juxtamembranous proteolysis. Sci. STKE 172, RE4.
9. Goudreau, N. and Llinas-Brunet, M. (2005). The therapeutic potential of NS3 protease inhibitors in HCV infection. Expert. Opin. Invest. Drugs 14, 1129-1144.
10. Hamill, P. and Jean, F. (2005). Enzymatic characterization of membrane-associated hepatitis C virus NS3-4A heterocomplex serine protease activity expressed in human cells. Biochemistry 44, 6586-6596.
11. Jean, F., Basak, A., DiMaio, J., Seidah, N.G., and Lazure, C. (1995a). An internally quenched fluorogenic substrate of prohormone convertase 1 and furin leads to a potent prohormone convertase inhibitor. Biochem. J. 307, 689-695.
12. Jean, F., Boudreault, A., Basak, A., Seidah, N.G., and Lazure, C. (1995b). Fluorescent peptidyl substrates as an aid in studying the substrate specificity of human prohormone convertase PC1 and human furin and designing a potent irreversible inhibitor. J. Biol. Chem. 270, 19225-19231.
13. Jones, J., Heim, R., Hare, E., Stack, J., and Pollok, B.A. (2000). Development and application of a GFP-FRET intracellular caspase assay for drug screening. J. Biomol. Screen. 5, 307-318.
14. Kim, S.Y., Park, K.W., Lee, Y.J., Back, S.H., Goo, J.H., Park, O.K., Jang, S.K., and Park, W.J. (2000). In vivo determination of substrate specificity of hepatitis C virus NS3 protease: genetic assay for site-specific proteolysis. Anal. Biochem. 284, 42-48.
15. Lamarre, D., Anderson, P.C., Bailey, M., Beulieu, P., Bolger, G., Bonneau, P., Bos, M., Cameron, D.R., Cartier, M., Cordingley, M.G., et al. (2003). An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus. Nature 426, 186-189.
16. Li, K., Foy, E., Ferreon, J.C., Nakamura, M., Ferreon, A.C., Ikeda, M., Ray, S.C., Gale, M. Jr., and Lemon, S.M. (2005a). Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc. Natl. Acad. Sci. USA 102, 2992-2997.
17. Li, X.D., Sun, L., Seth, R.B., Pineda, G., and Chen, Z.J. (2005b). Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc. Natl. Acad. Sci. USA 102, 17717-17722.
18. Matz, M.V., Fradkov, A.F., Labas, Y.A., Savitsky, A.P., Zaraisky, A.G., Markelov, M.L., and Lukyanov, S.A. (1999). Fluorescent proteins from nonbioluminescent Anthozoa species. Nat. Biotechnol. 17, 969-973.
19. Moradpour, D., Evans, M.J., Gosert, R., Yuan, Z., Blum, H.E., Goff, S.P., Lindenbach, B.D., and Rice, C.M. (2004). Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes. J. Virol. 78, 7400-7409.
20. Moradpour, D., Brass, V., and Penin, F. (2005). Function follows form: the structure of the N-terminal domain of HCV NS5A. Hepatology 42, 732-735.
21. Mottola, G., Cardinali, G., Ceccacci, A., Trozzi, C., Bartholomew, L., Torrisi, M.R., Pedrazzini, E., Bonatti, S., and Migliaccio, G. (2002). Hepatitis C virus nonstructural proteins are localized in a modified endoplasmic reticulum of cells expressing viral subgenomic replicons. Virology 293, 31-43.
22. Netzel-Arnett, S., Hooper, J.D., Szabo, R., Madison, E.L., Quigley, J.P., Bugge, T.H., and Antalis, T.M. (2003). Membrane anchored serine proteases: a rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer. Cancer Metastasis Rev. 22, 237-258.
23. Richer, M.J., Juliano, L., Hashimoto, C., and Jean, F. (2004). Serpin mechanism of hepatitis C virus nonstructural 3 (NS3) protease inhibition: induced fit as a mechanism for narrow specificity. J. Biol. Chem. 279, 10222-10227.
24. Salonen, A., Ahola, T., and Kaariainen, L. (2005). Viral RNA replication in association with cellular membranes. Curr. Top. Microbiol. Immunol. 285, 139-173.
25. Schechter, I. and Berger, A. (1967). On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27, 157-162.
26. Tawa, P., Tam, J., Cassady, R., Nicholson, D.W., and Xanthoudakis, S. (2001). Quantitative analysis of fluorescent caspase substrate cleavage in intact cells and identification of novel inhibitors of apoptosis. Cell Death Differ. 8, 30-37.
27. Wolfe, M.S. and Kopan, R. (2004). Intramembrane proteolysis: theme and variations. Science 305, 1119-1123.
28. Wolk, B., Sansonno, D., Krausslich, H.G., Dammacco, F., Rice, C.M., Blum, H.E., and Moradpour, D. (2000). Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A expressed in tetracycline-regulated cell lines. J. Virol. 74, 2293-2304.
29. Zhang, R., Durkin, J., Windsor, W.T., McNemar, C., Ramanathan, L., and Le, H.V. (1997). Probing the substrate specificity of hepatitis C virus NS3 serine protease by using synthetic peptides. J. Virol. 71, 6208-6213.